Skip to content
Disclosery

Nextech Invest Ltd.

Follow

13F filer, CIK 1911010, Zurich, Switzerland

Nextech Invest Ltd. reported $712,297,259 across 15 holdings for the quarter ended 2024-09-30, in a 13F-HR filed 2024-11-14. Its ten largest share positions make up 90.92% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-24-118949

Period
2024-09-30
Reported value
$712M
Holdings
15
Top 10 weight
90.92%
New
2
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ALMSnew+1,476,998$15.8M
ZYMEnew+1,113,946$14M
Mersana Therapeutics Incadded+2,541,100$4.8M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
SPRYreduced-797,000-$11.6M
CGEMreduced-80,000-$1.34M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2024

Share positions as resolved from 13F-HR 0001104659-24-118949, largest first. % of portfolio is the value over $712,297,259, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 4,839,529 shares; 2023Q2: 4,839,529 shares; 2023Q3: 4,839,529 shares; 2023Q4: 6,296,740 shares; 2024Q1: 6,296,740 shares; 2024Q2: 6,296,740 shares; 2024Q3: 6,296,740 shares 6,296,740$286M40.09%0Timeline
TYRATYRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 2,518,582 shares; 2023Q2: 2,518,582 shares; 2023Q3: 2,518,582 shares; 2023Q4: 2,518,582 shares; 2024Q1: 4,055,861 shares; 2024Q2: 4,055,861 shares; 2024Q3: 4,055,861 shares 4,055,861$95.4M13.39%0Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 4,285,714 shares; 2023Q3: 4,285,714 shares; 2023Q4: 4,285,714 shares; 2024Q1: 5,285,714 shares; 2024Q2: 5,285,714 shares; 2024Q3: 5,285,714 shares 5,285,714$54.2M7.61%0Timeline
CARGO THERAPEUTICS INC COMCARGO THERAPEUTICS INC COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: 2,642,502 shares; 2024Q1: 2,642,502 shares; 2024Q2: 2,642,502 shares; 2024Q3: 2,642,502 shares 2,642,502$48.8M6.84%0
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: 5,533,980 shares; 2023Q4: 5,533,980 shares; 2024Q1: 5,533,980 shares; 2024Q2: 5,533,980 shares; 2024Q3: 5,533,980 shares 5,533,980$42.6M5.98%0Timeline
ARVNARVINAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 287,251 shares; 2023Q2: 287,251 shares; 2023Q3: 287,251 shares; 2023Q4: 1,695,645 shares; 2024Q1: 1,408,394 shares; 2024Q2: 1,408,394 shares; 2024Q3: 1,408,394 shares 1,408,394$34.7M4.87%0Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 625,485 shares; 2023Q2: 948,659 shares; 2023Q3: 1,196,409 shares; 2023Q4: 1,346,409 shares; 2024Q1: 3,846,409 shares; 2024Q2: 3,846,409 shares; 2024Q3: 3,846,409 shares 3,846,409$27.2M3.82%0Timeline
Mersana Therapeutics IncMersana Therapeutics IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: 5,978,327 shares; 2024Q1: 3,856,321 shares; 2024Q2: 9,526,146 shares; 2024Q3: 12,067,246 shares 12,067,246$22.8M3.2%+2,541,100
CGEMCULLINAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 1,221,145 shares; 2023Q2: 1,221,145 shares; 2023Q3: 1,221,145 shares; 2023Q4: 1,221,145 shares; 2024Q1: 1,221,145 shares; 2024Q2: 1,221,145 shares; 2024Q3: 1,141,145 shares 1,141,145$19.1M2.68%-80,000Timeline
SLNSILENCE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 952,400 shares; 2024Q2: 952,400 shares; 2024Q3: 952,400 shares 952,400$17.3M2.43%0Timeline
SPRYARS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 1,910,029 shares; 2023Q2: 1,910,029 shares; 2023Q3: 1,910,029 shares; 2023Q4: 1,910,029 shares; 2024Q1: 1,910,029 shares; 2024Q2: 1,910,029 shares; 2024Q3: 1,113,029 shares 1,113,029$16.1M2.27%-797,000Timeline
ALMSALUMIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 1,476,998 shares 1,476,998$15.8M2.21%newTimeline
CNTXCONTEXT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: 7,419,355 shares; 2024Q3: 7,419,355 shares 7,419,355$14.5M2.04%0Timeline
ZYMEZYMEWORKS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 1,113,946 shares 1,113,946$14M1.96%newTimeline
BOLDBOUNDLESS BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 1,228,069 shares; 2024Q2: 1,228,069 shares; 2024Q3: 1,228,069 shares 1,228,069$4.26M0.6%0Timeline

How Q3 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-24-118949 base2024-11-14acceptance time not in the bulk data set